Holen Sie sich die Stockscreener-App
58.51
2.90%
-1.75
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$60.26
Offen:
$60.57
24-Stunden-Volumen:
2.26M
Relative Volume:
1.04
Marktkapitalisierung:
$9.12B
Einnahmen:
$1.17B
Nettoeinkommen (Verlust:
$150.71M
KGV:
62.24
EPS:
0.94
Netto-Cashflow:
$245.03M
1W Leistung:
-5.14%
1M Leistung:
-4.71%
6M Leistung:
+13.55%
1J Leistung:
-23.70%
1-Tages-Spanne:
$58.24
$60.59
1-Wochen-Bereich:
$58.24
$61.69
52-Wochen-Spanne:
$46.01
$79.28
Bio Techne Corp Stock (TECH) Company Profile
Firmenname
Bio Techne Corp
Sektor
Branche
Telefon
612-379-8854
Adresse
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Vergleichen Sie TECH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
58.51 | 9.39B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-08-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2025-07-09 | Eingeleitet | TD Cowen | Buy |
| 2025-05-30 | Eingeleitet | Wells Fargo | Overweight |
| 2025-04-09 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-02-08 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-02-02 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-07 | Eingeleitet | UBS | Buy |
| 2023-08-28 | Eingeleitet | William Blair | Outperform |
| 2023-01-10 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | Hochstufung | Stifel | Hold → Buy |
| 2021-01-25 | Bestätigt | The Benchmark Company | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-07-15 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | Herabstufung | Stifel | Buy → Hold |
| 2020-05-14 | Eingeleitet | The Benchmark Company | Buy |
| 2020-01-08 | Fortgesetzt | Stephens | Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-02 | Hochstufung | Janney | Neutral → Buy |
| 2019-01-14 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-10-17 | Eingeleitet | Goldman | Neutral |
| 2018-06-15 | Eingeleitet | Argus | Buy |
| 2017-07-13 | Eingeleitet | Wells Fargo | Market Perform |
| 2017-02-09 | Eingeleitet | Citigroup | Buy |
| 2017-01-18 | Eingeleitet | Deutsche Bank | Buy |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2013-09-20 | Hochstufung | Robert W. Baird | Neutral → Outperform |
Alle ansehen
Bio Techne Corp Aktie (TECH) Neueste Nachrichten
4D Advisors LLC Makes New $2.06 Million Investment in Bio-Techne Corp $TECH - MarketBeat
GMP Cytokine Market and Competition Outlook to 2031: Growing at 8.4% CAGR, Led by Bio-Techne, PeproTech, CellGenix Among OthersResearchAndMarkets.com - The AI Journal
Osterweis Capital Management Inc. Has $7.70 Million Stake in Bio-Techne Corp $TECH - MarketBeat
Here’s Why BioTechne (TECH) Traded Lower in Q3 - Yahoo Finance
Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology - Investing News Network
Bio-techne and Wyss Center partner to develop automated 3D multiomics - Investing.com
Bio-Techne (NASDAQ: TECH) and Wyss Geneva to develop automated 3D multiomics workflow - Stock Titan
Does Bio-Techne’s Recent Weakness Offer an Opportunity After Its Cell and Gene Therapy Push? - Yahoo Finance
Bio-Techne Announces Expanded Launch Of Next-Generation Leo System - Nasdaq
Bio-Techne Launches the Enhanced Leo System Delivering Advanced Multiplexing and High-Throughput Protein Analysis - Investing News Network
Bio-techne ships enhanced Leo System with expanded detection capabilities - Investing.com
Bio-Techne (NASDAQ: TECH) debuts Leo system with dual-channel fluorescence - Stock Titan
Transcript : Bio-Techne Corporation Presents at 53rd Annual Nasdaq Investor Conference, Dec-09-2025 09 - marketscreener.com
Bio-Techne Corp. stock outperforms competitors despite losses on the day - MarketWatch
Cresset Asset Management LLC Boosts Holdings in Bio-Techne Corp $TECH - MarketBeat
Brown Capital Management LLC Sells 94,825 Shares of Bio-Techne Corp $TECH - MarketBeat
1832 Asset Management L.P. Takes $7.72 Million Position in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corporation (TECH): A Bull Case Theory - Finviz
Norges Bank Buys New Stake in Bio-Techne Corp $TECH - MarketBeat
Russell Investments Group Ltd. Sells 23,984 Shares of Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp $TECH Holdings Reduced by Hsbc Holdings PLC - MarketBeat
How analysts revise price targets for Bio Techne Corporation (TE1) stockWeekly Market Report & Accurate Intraday Trading Signals - Newser
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Bio-Techne Corp $TECH Position Increased by Granite Investment Partners LLC - MarketBeat
Can Bio Techne Corporation stock reach $100 price targetWeekly Profit Report & AI Forecast Swing Trade Picks - Newser
Will Bio Techne Corporation (TE1) stock gain from green policies2025 Volatility Report & Real-Time Chart Pattern Alerts - Newser
How Bio Techne Corporation stock compares to market leadersQuarterly Investment Review & Weekly Watchlist of Top Performers - Newser
Edgestream Partners L.P. Has $11.81 Million Holdings in Bio-Techne Corp $TECH - MarketBeat
Prudential Financial Inc. Trims Holdings in Bio-Techne Corp $TECH - MarketBeat
Capital Fund Management S.A. Invests $4.89 Million in Bio-Techne Corp $TECH - MarketBeat
Mackenzie Financial Corp Raises Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
Rhumbline Advisers Has $15.16 Million Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp $TECH Shares Bought by JPMorgan Chase & Co. - MarketBeat
Grandeur Peak Global Advisors LLC Has $7.13 Million Stock Position in Bio-Techne Corp $TECH - MarketBeat
Charles Schwab Investment Management Inc. Boosts Position in Bio-Techne Corp $TECH - MarketBeat
Is Bio Techne Corporation stock supported by strong cash flows2025 Major Catalysts & Advanced Technical Analysis Signals - BỘ NỘI VỤ
Bio-Techne Corp $TECH Shares Sold by Neuberger Berman Group LLC - MarketBeat
Legal & General Group Plc Cuts Position in Bio-Techne Corp $TECH - MarketBeat
XTX Topco Ltd Boosts Position in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne (TECH): Assessing Valuation After ACA Subsidy Extension Buzz Boosts Investor Sentiment - simplywall.st
Bio-Techne (TECH): Evaluating Valuation After ACA Subsidy Extension Boosts Market Sentiment - Yahoo Finance
Swiss National Bank Has $15.52 Million Holdings in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Braces for a Biotech Funding Revival—Is a Major Upswing Ahead? - Smartkarma
SG Americas Securities LLC Sells 39,245 Shares of Bio-Techne Corp $TECH - MarketBeat
Ensign Peak Advisors Inc Trims Holdings in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp $TECH Shares Acquired by American Century Companies Inc. - MarketBeat
Rhenman & Partners Asset Management AB Takes Position in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp (TECH) Stock Forecasts - Yahoo! Finance Canada
Bio-Techne Corp. Stock Underperforms Wednesday When Compared To Competitors - 富途牛牛
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Bio-Techne Corp $TECH Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Finanzdaten der Bio Techne Corp-Aktie (TECH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.08%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):